{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:20:24Z","timestamp":1790360424092,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","europeanneuropsychopharmacology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.euroneuro.2014.04.003","type":"journal-article","created":{"date-parts":[[2014,5,4]],"date-time":"2014-05-04T20:16:26Z","timestamp":1399234586000},"page":"1415-1423","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Repeated but not acute treatment with \u22069-tetrahydrocannabinol disrupts prepulse inhibition of the acoustic startle: Reversal by the dopamine D2\/3 receptor antagonist haloperidol"],"prefix":"10.1016","volume":"24","author":[{"given":"Benjamin B.","family":"Tournier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Ginovart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2014.04.003_bib1","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s00213-004-1941-4","article-title":"The CB receptor agonist WIN 55,212-2 fails to elicit disruption of prepulse inhibition of the startle in Sprague-Dawley rats","volume":"177","author":"Bortolato","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.euroneuro.2014.04.003_bib2","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00213-007-0721-3","article-title":"Heterozygous neuregulin 1 mice are more sensitive to the behavioural effects of Delta9-tetrahydrocannabinol","volume":"192","author":"Boucher","year":"2007","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.euroneuro.2014.04.003_bib3","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1001\/archpsyc.1990.01810140081011","article-title":"Sensorimotor gating and schizophrenia. Human and animal model studies","volume":"47","author":"Braff","year":"1990","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.04.003_bib4","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s002130100810","article-title":"Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies","volume":"156","author":"Braff","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.euroneuro.2014.04.003_bib5","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1124\/mol.60.1.155","article-title":"Evidence for a new G protein-coupled cannabinoid receptor in mouse brain","volume":"60","author":"Breivogel","year":"2001","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.euroneuro.2014.04.003_bib6","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.brainres.2011.12.007","article-title":"Stereochemical and neuroanatomical selectivity of pramipexole effects on sensorimotor gating in rats","volume":"1437","author":"Chang","year":"2012","journal-title":"Brain Res."},{"key":"10.1016\/j.euroneuro.2014.04.003_bib7","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00406-009-0024-2","article-title":"Cannabis and psychosis\/schizophrenia: human studies","volume":"259","author":"D\u05f3Souza","year":"2009","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.euroneuro.2014.04.003_bib8","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1176\/ajp.148.11.1474","article-title":"Dopamine in schizophrenia: a review and reconceptualization","volume":"148","author":"Davis","year":"1991","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.04.003_bib9","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s00213-004-1851-5","article-title":"Sensorimotor gating in mice is disrupted after AM404, an anandamide reuptake and degradation inhibitor","volume":"175","author":"Fernandez-Espejo","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.euroneuro.2014.04.003_bib10","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/smi.2460040407","article-title":"Anxiolytic and anxiogenic drugs: changes in behaviour and endocrine responses","volume":"4","author":"File","year":"1988","journal-title":"Stress Med."},{"key":"10.1016\/j.euroneuro.2014.04.003_bib11","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.tics.2006.02.008","article-title":"Schizophrenia, ketamine and cannabis: evidence of overlapping memory deficits","volume":"10","author":"Fletcher","year":"2006","journal-title":"Trends Cognit. Sci."},{"key":"10.1016\/j.euroneuro.2014.04.003_bib12","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.bbr.2011.05.018","article-title":"Delta(9)-THC and WIN55,212-2 affect brain tissue levels of excitatory amino acids in a phenotype-, compound, dose-, and region-specific manner","volume":"224","author":"Galanopoulos","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.euroneuro.2014.04.003_bib13","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s002130100811","article-title":"Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review","volume":"156","author":"Geyer","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.euroneuro.2014.04.003_bib14","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1038\/npp.2012.91","article-title":"Chronic Delta(9)-tetrahydrocannabinol exposure induces a sensitization of dopamine D(2)\/(3) receptors in the mesoaccumbens and nigrostriatal systems","volume":"37","author":"Ginovart","year":"2012","journal-title":"Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2014.04.003_bib15","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1176\/jnp.8.1.60","article-title":"Preliminary evidence of an association between sensorimotor gating and distractibility in psychosis","volume":"8","author":"Karper","year":"1996","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.euroneuro.2014.04.003_bib16","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1177\/0269881105057516","article-title":"Chronic cannabis use is associated with attention-modulated reduction in prepulse inhibition of the startle reflex in healthy humans","volume":"20","author":"Kedzior","year":"2006","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2014.04.003_bib17","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ejphar.2007.01.032","article-title":"Attention-dependent reduction in prepulse inhibition of the startle reflex in cannabis users and schizophrenia patients\u2014a pilot study","volume":"560","author":"Kedzior","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2014.04.003_bib18","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00008877-200109000-00007","article-title":"Dopamine receptors in the brains of schizophrenia patients: a meta-analysis of the findings","volume":"12","author":"Kestler","year":"2001","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.euroneuro.2014.04.003_bib19","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1126\/science.179.4071.391","article-title":"Delta-9-tetrahydrocannabinol: localization in body fat","volume":"179","author":"Kreuz","year":"1973","journal-title":"Science"},{"key":"10.1016\/j.euroneuro.2014.04.003_bib20","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.schres.2007.12.481","article-title":"Uncontrollable voices and their relationship to gating deficits in schizophrenia","volume":"101","author":"Kumari","year":"2008","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2014.04.003_bib21","doi-asserted-by":"crossref","first-page":"19144","DOI":"10.1073\/pnas.0509588102","article-title":"The cannabinoid agonist WIN55,212-2 increases intracellular calcium via CB1 receptor coupling to Gq\/11 G proteins","volume":"102","author":"Lauckner","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.euroneuro.2014.04.003_bib22","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00213-010-1896-6","article-title":"A follow-up study: acute behavioural effects of Delta(9)-THC in female heterozygous neuregulin 1 transmembrane domain mutant mice","volume":"211","author":"Long","year":"2010","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.euroneuro.2014.04.003_bib23","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1017\/S1461145709990605","article-title":"A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL\/6JArc mice","volume":"13","author":"Long","year":"2010","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2014.04.003_bib24","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.pbb.2005.02.017","article-title":"Cognitive consequences of cannabis use: comparison with abuse of stimulants and heroin with regard to attention, memory and executive functions","volume":"81","author":"Lundqvist","year":"2005","journal-title":"Pharmacol., Biochem., Behav."},{"key":"10.1016\/j.euroneuro.2014.04.003_bib25","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.bbr.2005.07.009","article-title":"The effect of Delta9-tetrahydrocannabinol on sensorimotor gating in socially isolated rats","volume":"166","author":"Malone","year":"2006","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.euroneuro.2014.04.003_bib26","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/BF00212846","article-title":"Dopaminergic stimulation disrupts sensorimotor gating in the rat","volume":"94","author":"Mansbach","year":"1988","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.euroneuro.2014.04.003_bib27","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.drugalcdep.2010.11.020","article-title":"Failure to sustain prepulse inhibition in adolescent marijuana users","volume":"116","author":"Mathias","year":"2011","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.euroneuro.2014.04.003_bib28","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.pbb.2006.05.018","article-title":"Antipsychotics improve Delta9-tetrahydrocannabinol-induced impairment of the prepulse inhibition of the startle reflex in mice","volume":"84","author":"Nagai","year":"2006","journal-title":"Pharmacol., Biochem. Behav."},{"key":"10.1016\/j.euroneuro.2014.04.003_bib29","first-page":"11","article-title":"Toxicology and pharmacology of cannabis sativa with special reference to \u03949-THC","volume":"24S","author":"Nahas","year":"1972","journal-title":"Bull. Narc."},{"key":"10.1016\/j.euroneuro.2014.04.003_bib30","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00213-008-1220-x","article-title":"Effects of nicotine on quinpirole- and dizocilpine (MK-801)-induced sensorimotor gating impairments in rats","volume":"200","author":"Nespor","year":"2008","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.euroneuro.2014.04.003_bib31","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1124\/jpet.106.101287","article-title":"Pharmacological evaluation of cannabinoid receptor ligands in a mouse model of anxiety: further evidence for an anxiolytic role for endogenous cannabinoid signaling","volume":"318","author":"Patel","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.euroneuro.2014.04.003_bib32","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1001\/archpsyc.56.3.277","article-title":"Sensorimotor gating and thought disturbance measured in close temporal proximity in schizophrenic patients","volume":"56","author":"Perry","year":"1999","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.04.003_bib33","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1001\/archpsyc.58.10.909","article-title":"Neuropsychological performance in long-term cannabis users","volume":"58","author":"Pope","year":"2001","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.04.003_bib34","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1038\/sj.npp.1300396","article-title":"Prepulse inhibition and habituation of acoustic startle response in male MDMA (\u2018ecstasy\u2019) users, cannabis users, and healthy controls","volume":"29","author":"Quednow","year":"2004","journal-title":"Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2014.04.003_bib35","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.psyneuen.2010.07.002","article-title":"Cortisol rapidly disrupts prepulse inhibition in healthy men","volume":"36","author":"Richter","year":"2011","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.euroneuro.2014.04.003_bib36","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1369-1600.2008.00110.x","article-title":"Puberty as a highly vulnerable developmental period for the consequences of cannabis exposure","volume":"13","author":"Schneider","year":"2008","journal-title":"Addict. Biol."},{"key":"10.1016\/j.euroneuro.2014.04.003_bib37","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/00008877-200509000-00018","article-title":"Behavioral effects in adult rats of chronic prepubertal treatment with the cannabinoid receptor agonist WIN 55,212-2","volume":"16","author":"Schneider","year":"2005","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.euroneuro.2014.04.003_bib38","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00213-009-1679-0","article-title":"Alterations to pre-pulse inhibition (PPI) in chronic cannabis users are secondary to sustained attention deficits","volume":"207","author":"Scholes","year":"2009","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.euroneuro.2014.04.003_bib39","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/hup.1217","article-title":"Cannabis use and sensorimotor gating in patients with schizophrenia and healthy controls","volume":"26","author":"Scholes-Balog","year":"2011","journal-title":"Hum. Psychopharmacol."},{"issue":"5","key":"10.1016\/j.euroneuro.2014.04.003_bib40","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1037\/a0029117","article-title":"Residual effects of cannabis use on neurocognitive performance after prolonged abstinence: a meta-analysis","volume":"220","author":"Schreiner","year":"2012","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2014.04.003_bib41","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1016\/0024-3205(95)00197-E","article-title":"Do cognitive impairments recover following cessation of cannabis use?","volume":"56","author":"Solowij","year":"1995","journal-title":"Life Sci."},{"key":"10.1016\/j.euroneuro.2014.04.003_bib42","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/0006-3223(94)00178-6","article-title":"Differential impairments of selective attention due to frequency and duration of cannabis use","volume":"37","author":"Solowij","year":"1995","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.04.003_bib43","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1001\/jama.287.9.1123","article-title":"Cognitive functioning of long-term heavy cannabis users seeking treatment","volume":"287","author":"Solowij","year":"2002","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.euroneuro.2014.04.003_bib44","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.euroneuro.2009.09.004","article-title":"Cannabinoid self-administration attenuates PCP-induced schizophrenia-like symptoms in adult rats","volume":"20","author":"Spano","year":"2010","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2014.04.003_bib45","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s002130100799","article-title":"Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges","volume":"156","author":"Swerdlow","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.euroneuro.2014.04.003_bib46","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S0022-3565(25)23018-X","article-title":"Effects of spiperone, raclopride, SCH 23390 and clozapine on apomorphine inhibition of sensorimotor gating of the startle response in the rat","volume":"256","author":"Swerdlow","year":"1991","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.euroneuro.2014.04.003_bib47","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0361-9230(01)00646-3","article-title":"A systems model of altered consciousness: integrating natural and drug-induced psychoses","volume":"56","author":"Vollenweider","year":"2001","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.euroneuro.2014.04.003_bib48","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0893-133X(01)00261-5","article-title":"Dopamine D(2) receptor occupancy is a common mechanism underlying animal models of antipsychotics and their clinical effects","volume":"25","author":"Wadenberg","year":"2001","journal-title":"Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2014.04.003_bib49","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF02244341","article-title":"Intra-accumbens infusion of quinpirole impairs sensorimotor gating of acoustic startle in rats","volume":"113","author":"Wan","year":"1993","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.euroneuro.2014.04.003_bib50","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.euroneuro.2010.02.011","article-title":"The effects of the dopamine D2 agonist sumanirole on prepulse inhibition in rats","volume":"20","author":"Weber","year":"2010","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2014.04.003_bib51","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.brainres.2008.11.081","article-title":"Behavioural disturbances and altered Fos protein expression in adult rats after chronic pubertal cannabinoid treatment","volume":"1253","author":"Wegener","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.euroneuro.2014.04.003_bib52","series-title":"Neuropsychopharmacology: The Fifth Generation of Progress","first-page":"833","article-title":"Neurochemical and neuropharmacological imaging in schizophrenia","author":"Weinberger","year":"2002"}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X14001254?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X14001254?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T17:32:07Z","timestamp":1746207127000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X14001254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":52,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S0924977X14001254"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2014.04.003","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repeated but not acute treatment with \u22069-tetrahydrocannabinol disrupts prepulse inhibition of the acoustic startle: Reversal by the dopamine D2\/3 receptor antagonist haloperidol","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2014.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. and ECNP. All rights reserved.","name":"copyright","label":"Copyright"}]}}